MUCOSAL MELANOMA
Clinical trials for MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for melanoma patients who Don't respond to standard immunotherapy
Disease control Recruiting nowThis study tests new combinations of immunotherapy drugs given before surgery to people with advanced melanoma that can be removed. The goal is to see if these combinations can reduce or eliminate the tumor before surgery, lowering the chance the cancer comes back. The trial is f…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo aims to keep rare melanoma at bay
Disease control Recruiting nowThis study tests whether adding cabozantinib to the immunotherapy drug nivolumab can prevent mucosal melanoma from returning after surgical removal. About 101 adults with this rare type of melanoma will receive either nivolumab alone or nivolumab plus cabozantinib. The goal is to…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New combo therapy targets rare melanoma in early trial
Disease control Recruiting nowThis study tests whether combining two drugs, axitinib and nivolumab, can shrink or control advanced mucosal melanoma that hasn't been treated before. About 20 adults with this rare cancer will receive the combination. If the cancer worsens, some may also get targeted radiation o…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Blood test hunts down lingering melanoma, guides targeted immunotherapy
Disease control Recruiting nowThis study is for people with high-risk melanoma who have had surgery to remove their cancer. It uses a special blood test to look for tiny bits of tumor DNA left in the body. If found, participants receive either a combination of two immunotherapy drugs or one drug alone to try …
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Melanoma patients get immunotherapy shots directly into tumors before surgery
Disease control Recruiting nowThis study tests whether injecting two immunotherapy drugs (ipilimumab and nivolumab) directly into melanoma tumors before surgery can shrink or eliminate the cancer while causing fewer side effects than standard IV treatment. About 50 adults with stage III melanoma that can be s…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
New drug combo aims to keep rare skin cancer from returning
Disease control Recruiting nowThis study is for people with a rare type of skin cancer called mucosal melanoma that has been completely removed by surgery and tests positive for PD-L1. The trial compares the effects of adding the immunotherapy drug sintilimab to standard chemotherapy versus chemotherapy alone…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New drug targets Hard-to-Treat melanoma in early trial
Disease control Recruiting nowThis early-phase trial tests an investigational drug called [225Ac]Ac-A9-3408 in 50 adults with melanoma that has spread or cannot be removed by surgery. The main goals are to find the safest dose and understand side effects. Participants receive the drug once every 6 weeks for u…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC